KY-02327 structure
|
Common Name | KY-02327 | ||
---|---|---|---|---|
CAS Number | 2093407-25-9 | Molecular Weight | 373.453 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H27N3O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of KY-02327KY-02327 is an orally active, small molecule inhibitor of the Dishevelled (Dvl)-CXXC5 interaction with IC50 of 3.1 uM, a metabolically stabilized KY-02061 analog; KY-02327 is more stable by 2.3-fold and 1.3-fold than KY-02061 in rat liver microsomes and in human hepatocytes, respectively; shows enhanced effect on induction of ALP activity of osteoblast cells compared with KY-02061; activates the Wnt/β-catenin pathway, promotes osteoblast differentiation, and rescues BMD, bone volume, and trabecular bone structures in variectomized (OVX) mouse model. |
Name | KY-02327 |
---|
Description | KY-02327 is an orally active, small molecule inhibitor of the Dishevelled (Dvl)-CXXC5 interaction with IC50 of 3.1 uM, a metabolically stabilized KY-02061 analog; KY-02327 is more stable by 2.3-fold and 1.3-fold than KY-02061 in rat liver microsomes and in human hepatocytes, respectively; shows enhanced effect on induction of ALP activity of osteoblast cells compared with KY-02061; activates the Wnt/β-catenin pathway, promotes osteoblast differentiation, and rescues BMD, bone volume, and trabecular bone structures in variectomized (OVX) mouse model. |
---|---|
References | References 1. Kim HY, et al. EMBO Mol Med. 2016 Apr 1;8(4):375-87. View Related Products by Target Dishevelled |
Molecular Formula | C20H27N3O4 |
---|---|
Molecular Weight | 373.453 |
Storage condition | -20°C |